The group’s principle activity is to create a national network of branded outpatient specialty clinics, HemoTherapy Centers(TM), and hospital based services where blood therapies can be delivered efficiently. Customers served by the group include university teaching hospitals, hospital groups, health plans, pharmaceutical and biotech companies. The group’s services include aquapheresis, therapeutic plasma exchange, and plasma adsorption. The group operates from United States.
